THE ANTI IL-23/IL-12 AGENT USTEKINUMAB IS AN EFFECTIVE AND SAFE INDUCTION THERAPY IN PATIENTS WITH CROHN'S DISEASE REFRACTORY OR INTOLERANT TO ANTI-TNF: A MULTICENTRE ITALIAN STUDY
Alessandro Gubbiotti 1
Brigida Barberio 1
Fabiana Zingone 1
Lorenzo Bertani 2
Antonio Ferronato 3
Renato Sablich 4
Maria Teresa Urbano 4
Maria Giulia Demarzo 5
Giorgia Bodini 5
Andrea Buda 6
Davide Massimi 1
Cesare Casadei 1
Linda Cingolani 1
Greta Lorenzon 1
Renata D'IncĂ 1
Edoardo Vincenzo Savarino 1
1 University of Padua, Padua, Italy
2 University of Pisa, Pisa, Italy
3 Azienda ULSS 7 Pedemontana, Santorso (Vi), Italy
4 Ospedale S.Maria degli Angeli, Pordenone, Italy
5 Policlinico San Martino, Genova, Italy
6 UOC Gastroenterology, Feltre, Italy
Session
IBD (Posters)
Conference
UEG Week Virtual 2020
Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]